Health · 27 views
One-time gene editing treatment lowers 'bad' cholesterol by up to 62%
Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, as part of a study involving UCL scientists.
Summary
Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, as part of a study involving UCL scientists. Initial results from the research, supported by BRC-supported clinicians from UCL, UCLH and Barts Health NHS Trust, highlight the potential of the therapy as a one-time treatment for high cholesterol, which could remove the need for regular medication to lower the risk of heart disease.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Brain aging may be detected decades before symptoms appear, with links to gut healthContinue reading
- Blood and gene tests predict Alzheimer's symptoms three to six years aheadContinue reading
- ‘They’re lifesavers’: the Birmingham clinic giving hope to traumatised asylum seekersContinue reading
- New findings link obesity to loss of natural breast cancer protectionContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow